Story 12

Society-funded research leads to dramatically improved survival rates

Luana Locke is a Canadian Cancer Society volunteer who knows first-hand how the research we fund can benefit patients. Luana has Li-Fraumeni syndrome, a hereditary disease that significantly increases a person's risk of developing cancer. She has lost several family members to cancer and her children have the gene that causes Li-Fraumeni syndrome.

"My life is my children, I want to be around for them," says Luana, "and I want my family's legacy of loss to end with this generation. That's what this research is empowering us to do."

Recently, a Toronto research team funded by the Society and led by Dr David Malkin developed an innovative screening and monitoring program that dramatically improves survival for adults and children with Li-Fraumeni syndrome. After following patients for over 5 years, their research found that patients involved in the surveillance program had a 100% survival rate after cancer was detected. For those not under surveillance, the survival rate was only 21%.

This new surveillance protocol has already been adopted by dozens of pediatric cancer centres around the world.

The Canadian Cancer Society funds more research into more types of cancer than any other national charity in Canada. Learn more about the exciting research we are currently funding.